UK stock picks spotlight Diaceutics, Pets at Home and Autotrader Group

Traders Union
All News
Financial News
UK stock picks and outlook

Highlights

Diaceutics annual recurring revenue increases 19 per cent to £20 million and order book rises 56 per cent to £38.9 million, driven by growing precision medicine demand.
Pets at Home's underlying pre-tax profit drops 30.2 per cent to £93 million despite 1 per cent consumer revenue growth to £1.98 billion, but price cuts show early signs of restoring volume.
Autotrader Group shares fall 50 per cent year-on-year amid AI-driven risk to marketplace model, with revenue up 4 per cent to £624 million and £600 million capital return planned for 2024.

Sector trends shape this week’s calls

As reported by Financial Times, the three stock views hinge on distinct industry pressures, from expanding demand for precision medicine services to margin pressure in pet retail and competitive risks in online auto listings.

Diaceutics is presented as a buy on expectations that more targeted drug development will increase demand for the company’s diagnostic data and testing strategy services. The company collects testing data from U.S. diagnostic laboratories and sells it to pharmaceutical groups, with its network of lab relationships and acquired databases seen as creating a meaningful competitive moat.

In the year to December, Diaceutics says annual recurring revenue rises 19 per cent to £20 million and its order book increases 56 per cent to £38.9 million. The investment case also rests on the view that proprietary datasets gathered through customer relationships are more defensible than information that can be easily replicated by AI tools.

Pets at Home is also rated a buy, despite weaker recent earnings. Shoppers are moving toward supermarkets and discounters for pet food, hurting a retail division that accounts for about two-thirds of consumer revenue, while group consumer revenue edges up 1 per cent to £1.98 billion in the year to March 26 and underlying pre-tax profit falls 30.2 per cent to £93 million.

The retailer’s backers point to early signs of improvement after aggressive price cuts help restore volume growth. Management guides for underlying pre-tax profit of just under £100 million in 2027, and the shares trade on 12.4 times forward earnings, below their five-year average.

AI risk and valuation frame market impact

Autotrader Group receives a hold rating as investors assess how AI could alter the economics of online marketplaces. The company identifies the risk itself in its results, warning that AI tools may direct consumers straight to relevant adverts and reduce the need for dealers to pay for premium placement.

That threat matters because Autotrader is the leading automotive marketplace in the UK and generates revenue from dealerships listing vehicles and paying for visibility on its platform. Concerns that buyers may increasingly use AI agents rather than browse marketplace listings help explain why the share price is down 50 per cent over the past year.

Operating momentum is also softening. Revenue in the year to March rises 4 per cent to £624 million and slows further in the final months amid what the company describes as more difficult trading conditions, although management still plans to return £600 million to shareholders this year, including £500 million of buybacks.

Taken together, the three calls underline how investors are rewarding businesses with defensible data assets and credible turnaround potential, while becoming more cautious on digital platforms exposed to technological change. In that mix, Diaceutics is tied to long-term pharmaceutical infrastructure spending, Pets at Home to execution in a pressured consumer market, and Autotrader to whether its market position can withstand AI-led shifts in search and discovery.

Our earlier update on Alphabet (GOOGL) focused on the company’s expanded infrastructure capacity via a new Missouri data center alongside fresh scrutiny over Google AI Overviews after accuracy errors. We noted that these AI-related trust questions, together with mixed technical signals, kept the stock under short-term pressure and pointed to a largely range-bound trading outlook.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.